News and Trends 27 Jan 2023
Onxeo to study prostate cancer drug
French biotech company Onxeo S.A. has given an update on the clinical development program of its first-in-class drug candidate AsiDNA.…
Onxeo
- Latest Posts
News and Trends 2 Sep 2022
Cancer drug for children and young people with glioblastoma given to patients in study
Clinical-stage bio company, Onxeo, has announced that the first patients have been enrolled and treated in a phase 1b/2 clinical…
News and Trends 5 Nov 2018
DNA Repair Treatment Shows Early Promise for Treating Cancer
Paris-based Onxeo has proved in humans the potential of a cancer treatment that interferes with DNA repair mechanisms. The therapy…
News and Trends 25 Apr 2018
Cancer Treatment Targeting DNA Repair is Tested in Humans for the First Time
Onxeo has initiated a Phase I trial testing its first-in-class cancer treatment that works by inhibiting the repair of tumor…
ADVERTISEMENT
News and Trends 12 Sep 2017
French Nanoparticle Therapy Fails to Improve Liver Cancer Treatment in Phase III
Onxeo has announced Phase III results for its nanoparticle chemotherapy Livatag, which failed to improve the outcome for patients with…
News and Trends 28 May 2016
It’s Blood Cancer Day, how is Biotech fixing it?
Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need…
News and Trends 11 Nov 2015
French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients
Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers. Now their phase I clinical…
News and Trends 25 Sep 2015
Two French Biotechs are fighting in court…for nothing
We are all familiar with stories of lawsuits in the tech sector (e.g. remember the Apple and Samsung debacle?) but…
News and Trends 14 Nov 2014
Onxeo confirms receipt of the $25M milestone payment from its US partner Spectrum
Onxeo, an innovative company specializing in the development of orphan oncology drugs, founded after the merger of BioAlliance Pharma and…
